You just read:

Trovagene Announces Submission of Investigational New Drug Application to Initiate Phase 1b/2 Clinical Trial of PCM-075 for Acute Myeloid Leukemia

News provided by

Trovagene, Inc.

Jun 27, 2017, 08:00 ET